Advanced search
Publication Cover
Blood and Lymphatic Cancer: Targets and Therapy Volume 9, 2019 - Issue
Submit an article Journal homepage
117
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens

Fangwen Zhang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Ling Li1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Lei Zhang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Xin Li1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Xiaorui Fu1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Xinhua Wang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Jingjing Wu1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Zhenchang Sun1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Fei Kong1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
,
Liangliang Ren1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
&
Mingzhi Zhang1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, People’s Republic of China;2 Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan450052, People’s Republic of China
 show all
Pages 33-43 | Published online: 19 Aug 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.